Posted on May 4th, 2012 by
Researchers at the Mayo Clinic aim to provide an important tool for the characterization and investigation of bipolar disorder through development of the Mayo Clinic Bipolar Disorder Biobank. The project, part of a large general biobank at the institution, aims to provide a resource for clinical, genetic, and epidemiologic study of bipolar disorder, with the goal of individualized medicine in the future. Manuel E. Fuentes, MD, from the Mayo Clinic, Rochester, Minnesota, discussed some of the baseline clinical and demographic findings from the biobank registry here at the American Psychiatric Association's 2012 Annual Meeting.
Medscape Today by Susan Jeffrey
You must be logged-in to the site to post a comment.